1. Home
  2. JBLU vs VCEL Comparison

JBLU vs VCEL Comparison

Compare JBLU & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$5.28

Market Cap

2.1B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$45.05

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
VCEL
Founded
1998
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
JBLU
VCEL
Price
$5.28
$45.05
Analyst Decision
Sell
Strong Buy
Analyst Count
13
5
Target Price
$4.91
$57.75
AVG Volume (30 Days)
29.6M
604.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.83
60.00
EPS
N/A
N/A
Revenue
$9,062,000,000.00
$276,259,000.00
Revenue This Year
$12.11
$19.40
Revenue Next Year
$6.75
$18.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.45
52 Week Low
$3.87
$28.95
52 Week High
$6.46
$48.75

Technical Indicators

Market Signals
Indicator
JBLU
VCEL
Relative Strength Index (RSI) 45.64 52.92
Support Level $4.54 $44.56
Resistance Level $6.31 $48.75
Average True Range (ATR) 0.30 1.66
MACD -0.09 -0.63
Stochastic Oscillator 33.67 18.65

Price Performance

Historical Comparison
JBLU
VCEL

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: